Lithium Orotate.
May help stabilize mood and support mental well-being. Supplies lithium at trace mineral amounts, far below pharmaceutical levels. It is taken to support steady everyday mood, and human data at these amounts is still thin.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- Mood supportMental well being
What Lithium Orotate is, and what it does.
- Does it work
- Suits adults curious about trace lithium for everyday mood steadiness who are willing to check with a doctor first, especially about kidney and thyroid function.
- How much to take
- Start with 5mg to 20mg a day, the daily maintenance band. Read whether that figure means the whole salt or the elemental lithium, because those are very different numbers.
- Time to feel it
- Give it a few weeks. Nobody has measured a reliable onset at these amounts, and what people describe is gradual rather than same-day.
- The first dose
- Day one is quiet. The lithium ion distributes through body water within hours, which is a measurable event rather than a felt one.
- With regular use
- Weeks of daily use is the timescale people describe for a steadier mood. Nothing has been measured over that stretch at these amounts, so the accounts are personal rather than trial data.
- How well tolerated
- Trace amounts are usually well tolerated. Lithium concentrates in the thyroid and is cleared entirely by the kidney, so check with your doctor, especially if you take a diuretic.
- How it feels
- Subtle at most. Some people describe feeling a bit more even through a stressful week, and for others the change is slow enough that it only shows across a month.
- The overlooked benefit
- Orotate is much heavier than lithium, so a 5mg capsule of the salt carries only a fraction of that as lithium. Check which number your label means before comparing.
5 to 20mg a day is where Lithium Orotate works.
Source: Schrauzer 2002 J Am Coll Nutr (epidemiological); Marshall 2015 Int J Bipolar Disord.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
While some studies suggest potential benefits, the research on low-dose lithium orotate is limited. More rigorous studies are needed to confirm its effectiveness and safety.
- mood steadiness at trace intakesNarrative review
- glycogen synthase kinase 3 beta inhibitionIn vitro study
- brain lithium delivery from the orotate saltAnimal study
- trace lithium exposure and memory measures with ageing, an association rather than a causeCohort study
- renal clearance of lithium in parallel with sodiumNarrative review
Questions people ask about Lithium Orotate.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Lithium is reabsorbed along the sodium route in the proximal tubule, so sodium intake sets how much lithium the body holds. This applies to any lithium salt, including the orotate.
Lithium inhibits inositol monophosphatase and lowers recycling of free inositol inside the cell. Supplemental inositol acts directly against that step.
Caffeine raises renal lithium clearance, so a change in coffee intake shifts circulating lithium in the opposite direction.
Salicylates reduce renal prostaglandin signalling, which lowers lithium clearance and raises its level. The interaction is well recorded for prostaglandin inhibitors generally.
Lithium and magnesium compete at magnesium-dependent enzymes such as inositol monophosphatase and GSK-3. Magnesium status can modulate lithium's action at those sites.
Lithium accumulates in the thyroid and slows release of stored hormone, while iodine feeds hormone synthesis. Both act on the same normal thyroid pathway.
Bulk fibre in the same dose window lowers lithium absorption from the gut. Spacing the two apart preserves uptake.
A mild diuretic changes renal sodium handling, and lithium tracks sodium in the proximal tubule. Urine flow changes can move lithium levels either way.
Lithium is reabsorbed in the proximal tubule by the same transport machinery that handles sodium, so anything that raises sodium delivery or bicarbonate load pushes more lithium into the urine. Sodium bicarbonate does both. The result is lower lithium retention for a given intake. This is settled renal handling, described for the ion itself and independent of which anion it was paired with.
Sodium depletion, from sweat loss or a low-sodium pattern, raises proximal reabsorption of both sodium and lithium and so raises lithium retention. Sodium repletion does the opposite. An electrolyte product therefore shifts lithium handling in whichever direction it moves sodium and fluid balance. The relationship is well characterised for the lithium ion and is a reason retention is not stable across a training block or a hot week.
De novo pyrimidine synthesis starts when carbamoyl phosphate synthetase II takes an amide nitrogen from glutamine, and the pathway then runs through carbamoyl aspartate to dihydroorotate and orotate. Orotate in the body therefore comes from glutamine and aspartate carbon and nitrogen. This describes where the orotate anion sits in metabolism, and it says nothing about lithium itself.
Orotate phosphoribosyltransferase joins orotate to phosphoribosyl pyrophosphate, and decarboxylation then gives uridine monophosphate. PRPP is built from ribose 5-phosphate out of the pentose phosphate pathway. That places ribose availability downstream-adjacent to any orotate delivered as a counter-ion. The pathway is established; no clinical consequence of the pairing has been measured.
Orotate supplies the pyrimidine ring that becomes UMP and then dUMP, while folate as 5,10-methylene tetrahydrofolate donates the methyl group that converts dUMP to thymidylate. The two nutrients converge on one reaction from different directions. Orotic acid accumulation is a recognised biochemical marker when urea cycle flux is disturbed, which is a marker and not an outcome. No combination has been trialled.
Methionine synthase requires B12 to regenerate tetrahydrofolate from methyltetrahydrofolate, and without it the folate pool is trapped and thymidylate synthesis slows even when pyrimidine precursors are plentiful. Orotate contributes the pyrimidine ring on the other side of that reaction. The link is pathway architecture. Nothing here concerns lithium.
Green tea extract carries caffeine, and caffeine intake is associated with increased renal lithium clearance through changes in proximal sodium handling and urine flow. The size of that shift depends on the caffeine dose and on habitual intake, since tolerance to the diuretic effect develops. This is inference from lithium's known renal handling rather than a study of the two products together.
Lithium is filtered freely and reabsorbed in parallel with sodium, and distal tubule function that depends on potassium status contributes to the overall picture of how much is retained. Changing potassium intake alters that environment. The direction and size of the effect on lithium retention are not established with the precision the sodium relationship carries, which is why this sits below Established.
Talk to a doctor before taking Lithium Orotate if any of these apply to you: Kidney issues, Thyroid disorders, Pregnancy and breastfeeding, Drug interactions (especially with antidepressants and NSAIDs). These are flags to check first, not effects Lithium Orotate is known to cause.
Not medical advice. Show the label to your pharmacist.What Lithium Orotate actually does.
Lithium orotate is a simple salt: in water it splits into a lithium ion and an orotate ion, and from there the two travel and act as separate things in the body.
Orotic acid weighs far more than lithium, so actual lithium is a small fraction of the salt's weight, and a milligram figure on a label means very different things depending on whether it counts the salt or the element.
Orotate is a normal stepping stone your cells use when building pyrimidines, made from carbamoyl phosphate and aspartate on the way to uridine monophosphate.
Your kidneys filter lithium out and then pull roughly two thirds of it back in alongside sodium, which is why salt intake, hydration and diuresis all change how much you keep.
Where Lithium Orotate comes from.
Lithium is pulled from salt brines or rock, cleaned up into lithium carbonate, then combined with orotic acid so the two lock together as a solid that can be filtered out and dried. Orotic acid is made either in a reactor or by fermentation. Because the orotate part is much heavier than the lithium part, the milligrams on the label and the milligrams of actual lithium are two very different numbers.
From a mineral source, then refined and usually bound to a carrier so the body can take it up.
Lithium is recovered either from continental brines, concentrated in evaporation ponds over many months, or from spodumene ore that is mined, crushed and roasted to make the lithium leachable.
Purified brine or leachate is precipitated with sodium carbonate to give technical lithium carbonate, which is then refined. This is the same commodity intermediate the battery industry buys, and supplement-grade material branches off it.
Technical carbonate is redissolved and reprecipitated, or ion-exchanged, to remove sodium, potassium, calcium and heavy metal contaminants. Grade is set by contaminant specification, and material for oral use must meet it.
Refined lithium carbonate or hydroxide is reacted with orotic acid in water, releasing carbon dioxide or water and precipitating the poorly soluble lithium orotate. The orotic acid itself is made either by chemical synthesis or by microbial fermentation with orotate-accumulating strains.
The precipitate is filtered, washed to remove unreacted starting material, dried and milled. Assay confirms both the salt identity and the elemental lithium percentage, which is the number that actually governs dosing.
Getting Lithium Orotate from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Low-dose dietary lithium supplementation produced a measurable brain lithium signal on 7Li-MRI in healthy participants in an open-label study, indicating that supplemental doses can reach brain tissue detectably; a tissue signal is a marker, not a clinical outcome.Open-label trial. Neal et al., 2024 (Journal of Affective Disorders). PMID 38810780 ↗
- A survey of people who bought lithium as a supplement described their reasons, dosing patterns and self-reported experiences, and the authors note the responses are self-selected self-report, so the findings are associations and not measured effects.Cohort study. Strawbridge et al., 2025 (Canadian Journal of Psychiatry). PMID 40152059 ↗
- The review argues that lithium's effects are dose-dependent across a wide range and that low-dose and high-dose exposures should not be treated as the same exposure, which is directly relevant to how supplement-level lithium is interpreted.Narrative review. Manchia et al., 2024 (International Journal of Bipolar Disorders). PMID 38914810 ↗
- The review surveys how metal homeostasis, inflammatory signalling and oxidative stress interact in the aging brain and places lithium among the biologically active elements discussed in that literature.Narrative review. Lado et al., 2025 (Frontiers in Aging Neuroscience). PMID 41583005 ↗
These are the studies our verdict leans on, chosen from the 4 we read for Lithium Orotate. The full linked list is below.
The studies, linked.
1 source behind our Lithium Orotate verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialLiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical ResponseClinicalTrials.gov ↗PHASE1 · 40 participants · Not yet recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 320 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Lithium Orotate is, not how risky it is. A report is not proof Lithium Orotate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
